Treatment With Duloxetine for OCD Patients
NCT00399022 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2008-01-31
Summary
Testing the efficacy of the SNRI medication Duloxetine for treating OCD patients who did not respond to SSRI
Conditions
- OCD
Interventions
- DRUG
-
Duloxetine
Sponsors & Collaborators
-
Sheba Medical Center
lead OTHER_GOV
Principal Investigators
-
Joseph Zohar, MD · Chaim Sheba Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Israel
Study Locations
More Related Trials
-
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
NCT00849901 ·Status: COMPLETED ·Phase: PHASE3
-
Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder
NCT00105989 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adolescents With Depressive Disorder
NCT03395353 ·Status: TERMINATED ·Phase: PHASE3
-
Treatment of MDEs During the Course of Psychotic Disorders With Duloxetine
NCT00224302 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder
NCT00191061 ·Status: COMPLETED ·Phase: PHASE4
-
A Pilot Study Assessing Duloxetine's Efficacy in Atypical Depression
NCT00296699 ·Status: COMPLETED ·Phase: PHASE4
-
Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression
NCT00042562 ·Status: COMPLETED ·Phase: PHASE3
-
Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With Depression
NCT00073411 ·Status: COMPLETED ·Phase: PHASE3
-
Duloxetine Versus Duloxetine Plus Non-Drug Therapy for Depression
NCT00494377 ·Status: COMPLETED ·Phase: PHASE4
-
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
NCT00849693 ·Status: COMPLETED ·Phase: PHASE3
-
Switching to Duloxetine From Other Antidepressants
NCT00191932 ·Status: COMPLETED ·Phase: PHASE4
-
Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine Trials
NCT00191594 ·Status: COMPLETED ·Phase: PHASE3
-
Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease
NCT00437125 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Study of Duloxetine in Psychological Resilience
NCT00331799 ·Status: COMPLETED ·Phase: PHASE2
-
Duloxetine vs. Active Comparator in the Treatment of Patients With Depression
NCT00071695 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Neurobiology of Depression
NCT01051466 ·Status: COMPLETED ·Phase: PHASE4
-
Duloxetine vs. Active Comparator for the Treatment of Depression
NCT00067912 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain
NCT00191919 ·Status: COMPLETED ·Phase: PHASE3
-
Early Improvement in Individual Symptoms and Response to Antidepressants in Patients With Major Depressive Disorder
NCT02934035 ·Status: UNKNOWN
-
Duloxetine Versus Paroxetine for Major Depression
NCT00489775 ·Status: COMPLETED ·Phase: PHASE3
-
Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain
NCT00036335 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Duloxetine in Elderly Patients With Major Depressive Disorder
NCT00062673 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating the Safety and Tolerability of Abrupt Discontinuation of Saredutant in Patients With Depression
NCT00429260 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks Trial
NCT03121573 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of DOV 21,947 in the Treatment of Major Depressive Disorder
NCT00659347 ·Status: TERMINATED ·Phase: PHASE2